We only have this paper's title and publication details.
Read it at the sourcea dual mechanism: the reduction of STAT1 level and the HDAC inhibitor property of SCFAs.
No takes yet. Share an insight, caveat, or question.
Martin‐Gallausiaux et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: